Aethlon Medical (AEMD) Net Income towards Common Stockholders (2010 - 2026)

Aethlon Medical (AEMD) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$38.6 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders fell 5.99% year-over-year to -$38.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.9 million (down 0.51% YoY) and the FY2026 annual result came in at -$43.8 million, down 0.81% from the prior year.
• Net Income towards Common Stockholders fell to -$38.6 million in Q1 2026, from -$2.1 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$1.5 million in Q3 2025 to a low of -$38.6 million in Q1 2026.
• A 5-year average of -$12.1 million and a median of -$3.0 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 1264.34% — and 2025, when it surged 47.77%.
• Tracing AEMD's Net Income towards Common Stockholders over 5 years: stood at -$2.8 million in 2022, then decreased by 21.35% to -$3.5 million in 2023, then surged by 47.15% to -$1.8 million in 2024, then fell by 13.01% to -$2.1 million in 2025, then slumped by 1767.82% to -$38.6 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$38.6 million (Q1 2026), -$2.1 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.